| 2018 | Cell therapeutic agent for the treating cancer and combination therapy using same | 서해영, 김성수, 장다영, 정진화, 이영돈, 박진성 |
| 2011 | COMPOSITION FOR TREATING A CANCER COMPRISINGMESENCHYMAL STEM CELLS ENGINEERED TO EXPRESS SUICIDALGENE | 서해영, 장다영, 김성수, 유승완, 이영돈 |
| 2016 | Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas | 장다영, 김성수, 서해영 |
| 2017 | Effects of Adenoviral Gene Transduction on the Stemness of Human Bone Marrow Mesenchymal Stem Cells | 장다영, 서해영, 김성수 |
| 2013 | Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-β. | 장다영, 박진성, 조은혜, 이영돈, 김성수, 서해영 |
| 2013 | Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells. | 장다영, 박준성, 김세혁, 이영돈, 김성수, 서해영 |
| 2010 | The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. | 장다영, 유승완, 김세중, 조경기, 이영돈, 김성수, 서해영 |
| 2014 | Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. | 김성수, 장다영, 김욱환, 서해영, 이재호 |
| 2015 | Three-dimensional assessment of bystander effects of mesenchymal stem cells carrying a cytosine deaminase gene on glioma cells. | 장다영, 서해영, 김성수 |
